T80.82XA vs Z93
T80.82XA (Complication of immune effector cellular therapy, initial encounter) compared with Z93 (Artificial opening status), from the official CMS tabular data. Both may be reported when both conditions are documented (Excludes2).
Can these codes be reported together?
Yes, when both are documented. T80.82XA carries an Excludes2 note covering Z93: “artificial opening status (Z93.-)”
Excludes2 marks distinct conditions — both may be reported when both are documented.
Side by side
| T80.82XAComplication of immune effector cellular therapy, initial encounter | Z93Artificial opening status | |
|---|---|---|
| Billing status | Billable | Non-billable header |
| Classification | S00-T88 — Injury, Poisoning and Certain Other Consequences of External Causes (S00-T88) | Z00-Z99 — Factors Influencing Health Status and Contact with Health Services (Z00-Z99) |
| Definition | Complication of immune effector cellular therapy, initial encounter is a billable ICD-10-CM diagnosis code (T80.82A). | Artificial opening status is a non-billable ICD-10-CM category code (Z93). |
| 7th character | The appropriate 7th character is to be added to each code from category T80 | — |
| Includes | complications following perfusion Complication of chimeric antigen receptor (CAR-T) cell therapy Complication of IEC therapy | — |
| Use additional code | code to identify the specific complication, such as: cytokine release syndrome (D89.83-) immune effector cell-associated neurotoxicity syndrome (G92.0-) | — |
Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources